Is Crinetics Pharmaceuticals, Inc. (CRNX) a Buy, Sell, or Hold?
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$83.71 USD
$0.04 (0.05%)
- Volume
- 5.09M
- Average Volume
- 3.1M
- Market Capitalization
- $8.86B
- P/E Ratio
- -16.29
- Dividend Yield
- 0.00%
- Price Target
- $85.00
- Year High
- $83.89
- Year Low
- $25.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.60
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
27
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
43
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.4M
CRNX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CRNX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Vivaldi Coelho Rogerio | director | 2026-07-02 | S-Sale | 40 | 2026-07-07 |
| Deardorf Caren | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Deardorf Caren | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Fust Matthew K | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Fust Matthew K | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Nichols Weston | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Nichols Weston | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Vivaldi Coelho Rogerio | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Vivaldi Coelho Rogerio | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Bedrosian Camille L | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Bedrosian Camille L | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| WIERENGA WENDELL | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| WIERENGA WENDELL | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Okey Stephanie | director | 2026-06-18 | A-Award | 0 | 2026-06-22 |
| Okey Stephanie | director | 2026-06-18 | A-Award | 35.87 | 2026-06-22 |
| Okey Stephanie | director | 2026-06-17 | S-Sale | 35.62 | 2026-06-18 |
| Okey Stephanie | director | 2026-06-17 | S-Sale | 36.22 | 2026-06-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-05-29 | G-Gift | 0 | 2026-06-02 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 19.64 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 20.02 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 23.98 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | S-Sale | 40.1 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 19.64 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 23.98 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | 2026-04-08 | M-Exempt | 20.02 | 2026-04-10 |
| Knight Jeff E. | officer: Chief Operating Officer | 2026-03-16 | S-Sale | 37.11 | 2026-03-18 |
| Knight Jeff E. | officer: Chief Operating Officer | 2026-03-16 | S-Sale | 37.77 | 2026-03-18 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2026-03-16 | S-Sale | 37.11 | 2026-03-18 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2026-03-16 | S-Sale | 37.77 | 2026-03-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-03-16 | S-Sale | 37.11 | 2026-03-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-03-16 | S-Sale | 37.77 | 2026-03-18 |
| Vivaldi Coelho Rogerio | director | 2026-03-12 | S-Sale | 36.08 | 2026-03-13 |
| Vivaldi Coelho Rogerio | director | 2026-03-12 | S-Sale | 36.77 | 2026-03-13 |
| Okey Stephanie | director | 2026-03-03 | S-Sale | 39.67 | 2026-03-04 |
| Schilke Tobin | officer: Chief Financial Officer | 2026-03-03 | S-Sale | 39.67 | 2026-03-04 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-02-23 | A-Award | 0 | 2026-02-25 |
| Struthers Richard Scott | director, officer: President & CEO | 2026-02-23 | A-Award | 43.79 | 2026-02-25 |
| Schilke Tobin | officer: Chief Financial Officer | 2026-02-23 | A-Award | 0 | 2026-02-25 |
| Schilke Tobin | officer: Chief Financial Officer | 2026-02-23 | A-Award | 43.79 | 2026-02-25 |
| Knight Jeff E. | officer: Chief Operating Officer | 2026-02-23 | A-Award | 0 | 2026-02-25 |
| Knight Jeff E. | officer: Chief Operating Officer | 2026-02-23 | A-Award | 43.79 | 2026-02-25 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2026-02-23 | A-Award | 0 | 2026-02-25 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2026-02-23 | A-Award | 43.79 | 2026-02-25 |
| Kalofonos Isabel | officer: Chief Commercial Officer | 2026-02-23 | A-Award | 43.79 | 2026-02-25 |
| Kalofonos Isabel | officer: Chief Commercial Officer | 2026-02-23 | A-Award | 0 | 2026-02-25 |
| Kalofonos Isabel | officer: Chief Commercial Officer | 2026-01-05 | M-Exempt | 40.59 | 2026-01-07 |
| Kalofonos Isabel | officer: Chief Commercial Officer | 2026-01-05 | M-Exempt | 40.59 | 2026-01-07 |
| Kalofonos Isabel | officer: Chief Commercial Officer | 2026-01-05 | S-Sale | 55 | 2026-01-07 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-12-26 | M-Exempt | 1.91 | 2025-12-29 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-12-26 | M-Exempt | 1.91 | 2025-12-29 |
| Struthers Richard Scott | director, officer: President & CEO | 2025-12-18 | M-Exempt | 15.29 | 2025-12-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2025-12-18 | M-Exempt | 9.28 | 2025-12-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2025-12-18 | M-Exempt | 15.29 | 2025-12-18 |
| Struthers Richard Scott | director, officer: President & CEO | 2025-12-18 | M-Exempt | 9.28 | 2025-12-18 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-12-01 | M-Exempt | 16.89 | 2025-12-03 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-12-01 | M-Exempt | 16.89 | 2025-12-03 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-12-01 | S-Sale | 45.02 | 2025-12-03 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-11-03 | M-Exempt | 16.89 | 2025-11-05 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-11-03 | M-Exempt | 16.89 | 2025-11-05 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-11-03 | S-Sale | 42.65 | 2025-11-05 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-11-03 | S-Sale | 43.27 | 2025-11-05 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-10-01 | M-Exempt | 16.89 | 2025-10-03 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-10-01 | M-Exempt | 16.89 | 2025-10-03 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-10-01 | S-Sale | 41.81 | 2025-10-03 |
| Struthers Richard Scott | director, officer: President & CEO | 2025-09-26 | S-Sale | 45 | 2025-09-30 |
| Fust Matthew K | director | 2025-09-26 | M-Exempt | 1.91 | 2025-09-30 |
| Fust Matthew K | director | 2025-09-26 | S-Sale | 44.75 | 2025-09-30 |
| Fust Matthew K | director | 2025-09-26 | M-Exempt | 1.91 | 2025-09-30 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-09-02 | M-Exempt | 16.89 | 2025-09-04 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-09-02 | S-Sale | 32.1 | 2025-09-04 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-09-02 | M-Exempt | 16.89 | 2025-09-04 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-08-22 | M-Exempt | 16.89 | 2025-08-26 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-08-22 | M-Exempt | 16.89 | 2025-08-26 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-08-22 | S-Sale | 30.43 | 2025-08-26 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | 2025-08-20 | S-Sale | 29.18 | 2025-08-21 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-06-12 | M-Exempt | 9.28 | 2025-06-16 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-06-12 | M-Exempt | 1.91 | 2025-06-16 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-06-12 | M-Exempt | 1.91 | 2025-06-16 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-06-12 | S-Sale | 32.23 | 2025-06-16 |
| Betz Stephen F. | officer: Chief Scientific Officer | 2025-06-12 | M-Exempt | 9.28 | 2025-06-16 |
| Okey Stephanie | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Deardorf Caren | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Deardorf Caren | director | 2025-06-11 | A-Award | 32.33 | 2025-06-13 |
| Okey Stephanie | director | 2025-06-11 | A-Award | 32.33 | 2025-06-13 |
| Vivaldi Coelho Rogerio | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Vivaldi Coelho Rogerio | director | 2025-06-11 | A-Award | 32.33 | 2025-06-13 |
| Fust Matthew K | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Fust Matthew K | director | 2025-06-11 | A-Award | 32.33 | 2025-06-13 |
| Bedrosian Camille L | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Bedrosian Camille L | director | 2025-06-11 | A-Award | 32.33 | 2025-06-13 |